Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Sugarman

Showing results (81-90 of 349) with videos related to

Pageof 35
Sort By:
Clinical Trials (London, England)|November 12, 2021
Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerationsAndrew Garland, Kevin Weinfurt, Jeremy Sugarman
The American Journal of Bioethics : AJOB|November 30, 2022
Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?Andrew Garland, Stephanie Morain, Jeremy Sugarman
Regenerative Medicine|November 12, 2009
Of mice and men: skin cells, stem cells and ethical uncertaintiesJeremy Sugarman, Debra J H Mathews
The American Journal of Bioethics : AJOB|December 10, 2009
Categorizing empirical research in bioethics: why count the ways?Jeremy Sugarman, Nancy Kass, Ruth Faden
The Lancet. Digital Health|April 27, 2023
Decentralised clinical trials: ethical opportunities and challengesEffy Vayena, Alessandro Blasimme, Jeremy Sugarman
Development (Cambridge, England)|March 16, 2017
Ethical issues in human organoid and gastruloid researchMegan Munsie, Insoo Hyun, Jeremy Sugarman
JAMA|March 13, 2014
Shared savings in accountable care organizations: how to determine fair distributionsMatthew DeCamp, Jeremy Sugarman, Scott Berkowitz
Science (New York, N.Y.)|June 23, 2018
Emerging stem cell ethicsDouglas Sipp, Megan Munsie, Jeremy Sugarman
Accountability in Research|July 21, 2015
Anticipated Ethics and Regulatory Challenges in PCORnet: The National Patient-Centered Clinical Research NetworkJoseph Ali, Robert Califf, Jeremy Sugarman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2020
Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus VaccineAndrea Cox, Mark Sulkowski, Jeremy Sugarman
Pageof 35

Showing results (81-90 of 349) with videos related to

Sort By:
Pageof 35
Clinical Trials (London, England)|November 12, 2021
Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerationsAndrew Garland, Kevin Weinfurt, Jeremy Sugarman
The American Journal of Bioethics : AJOB|November 30, 2022
Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?Andrew Garland, Stephanie Morain, Jeremy Sugarman
Regenerative Medicine|November 12, 2009
Of mice and men: skin cells, stem cells and ethical uncertaintiesJeremy Sugarman, Debra J H Mathews
The American Journal of Bioethics : AJOB|December 10, 2009
Categorizing empirical research in bioethics: why count the ways?Jeremy Sugarman, Nancy Kass, Ruth Faden
The Lancet. Digital Health|April 27, 2023
Decentralised clinical trials: ethical opportunities and challengesEffy Vayena, Alessandro Blasimme, Jeremy Sugarman
Development (Cambridge, England)|March 16, 2017
Ethical issues in human organoid and gastruloid researchMegan Munsie, Insoo Hyun, Jeremy Sugarman
JAMA|March 13, 2014
Shared savings in accountable care organizations: how to determine fair distributionsMatthew DeCamp, Jeremy Sugarman, Scott Berkowitz
Science (New York, N.Y.)|June 23, 2018
Emerging stem cell ethicsDouglas Sipp, Megan Munsie, Jeremy Sugarman
Accountability in Research|July 21, 2015
Anticipated Ethics and Regulatory Challenges in PCORnet: The National Patient-Centered Clinical Research NetworkJoseph Ali, Robert Califf, Jeremy Sugarman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2020
Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus VaccineAndrea Cox, Mark Sulkowski, Jeremy Sugarman
Pageof 35